Innovative Drug Delivery Nanexa AB specializes in pioneering drug delivery systems through its PharmaShell® platform, offering opportunities to collaborate or license advanced delivery technologies forclusion in new pharmaceutical formulations or development projects.
Strategic Partnerships Recent collaborations with industry leaders such as Moderna and AstraZeneca demonstrate Nanexa's growing reputation and potential as a partner for large pharmaceutical companies seeking innovative delivery solutions.
Recognition and Validation Being recognized as a finalist in the Drug Delivery Technology category by Fierce Life Sciences and receiving regulatory approvals for data presentations at major conferences position Nanexa as a credible innovator, encouraging partnerships and investment.
Funding and Growth Securing recent financing of USD 750,000 and strategic advisory partnerships indicate active efforts to expand R&D capabilities and commercialize its technology, opening avenues for investors and collaborators interested in early-stage biotech firms.
Pipeline Progress Positive pharmacokinetic data for NEX-20 and ongoing development efforts present opportunities to integrate Nanexa’s drug delivery systems into potential co-development projects or licensing agreements with pharmaceutical companies.
$50M$100M
$100M$250M
$250M$500M
$50M$100M
$1B$10BNanexa AB uses 8 technology products and services including Open Graph, RSS, Microsoft 365, and more. Explore Nanexa AB's tech stack below.
| Nanexa AB Email Formats | Percentage |
| First.Last@nanexa.se | 100% |
| First.Last@nanexa.com | 67% |
| FLast@nanexa.com | 33% |
Pharmaceutical ManufacturingUppsala, Sweden11-50 Employees
Nanexa AB is a drug delivery company that focuses on the development of PharmaShell®, a new and pioneering drug delivery system that is considered to have great potential in a number of substance types and indication areas. Within the framework of PharmaShell®, Nanexa develops its own projects and has collaborative agreements with several pharmaceutical companies, including AstraZeneca.
Company Overview
Funding & FinancialsNanexa AB's revenue is estimated to be in the range of $1M
Funding & FinancialsNanexa AB's revenue is estimated to be in the range of $1M
1-888-653-2347 
support@leadiq.com